Session 4: State-of-the-Art in Coronary Surgery: What Does the Evidence Say?
All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.
Moderators
Joseph F. Sabik III, MD
Disclosure(s): Medtronic: Speakers Bureau/Honoraria, Consultant/Advisory Board
Jennifer Lawton, MD
Panelists
Mario Gaudino, MD, PhD
Disclosure(s): Abbott Vascular: Consultant/Advisory Board
Joseph B. Zwischenberger, MD
Disclosure(s): Avalon, Maquet: Royalties; Verthermia Acquisitions, Inc.: Consultant/Advisory Board
Presentations
- Atrial Management in the CABG Patient
Richard Whitlock, MD, PhD, FRCSC
Disclosure(s): AtriCure – Research Grant, Speakers Bureau/Honoraria; Procyrion – Chair DSMB; Boston Scientific – Research Grant
- Mechanical Circulatory Support in High-Risk CABG
Amit Pawale, MD
- FFR – Why It Matters in PCI, But Not in CABG
Mario Gaudino, MD, PhD
Disclosure(s): Abbott Vascular: Consultant/Advisory Board
- Contemporary Secondary Prevention
Subodh Verma, MD, PhD, FRCSC
Disclosure(s): Amarin, AstraZeneca, Bayer, Boehringer-Ingelheim, Canadian Medical and Surgical Knowledge Translation Research Group, Eli Lilly, HLS Therapeutics, Humber River Health, Janssen, Novartis, Novo Nordisk, Pfizer, PhaseBio, S & L Solutions Event Management Inc: Speakers Bureau; Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Eli Lilly, HLS Therapeutics, Janssen, Novartis, Novo Nordisk, Sanofi: Consultant/Advisory Board; Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Eli Lilly, HLS Therapeutics, Merck, Novartis, Novo Nordisk, Pfizer, PhaseBio, Sanofi: Other Research Support
Available Credit
- 1.50 ABS Accredited CME
- 1.50 ABTS Accredited CME
- 1.50 AMA PRA Category 1 Credit™
Price
All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.
Moderators
Joseph F. Sabik III, MD
Disclosure(s): Medtronic: Speakers Bureau/Honoraria, Consultant/Advisory Board
Jennifer Lawton, MD
Panelists
Mario Gaudino, MD, PhD
Disclosure(s): Abbott Vascular: Consultant/Advisory Board
Joseph B. Zwischenberger, MD
Disclosure(s): Avalon, Maquet: Royalties; Verthermia Acquisitions, Inc.: Consultant/Advisory Board
Presentations
- Atrial Management in the CABG Patient
Richard Whitlock, MD, PhD, FRCSC
Disclosure(s): AtriCure – Research Grant, Speakers Bureau/Honoraria; Procyrion – Chair DSMB; Boston Scientific – Research Grant
- Mechanical Circulatory Support in High-Risk CABG
Amit Pawale, MD
- FFR – Why It Matters in PCI, But Not in CABG
Mario Gaudino, MD, PhD
Disclosure(s): Abbott Vascular: Consultant/Advisory Board
- Contemporary Secondary Prevention
Subodh Verma, MD, PhD, FRCSC
Disclosure(s): Amarin, AstraZeneca, Bayer, Boehringer-Ingelheim, Canadian Medical and Surgical Knowledge Translation Research Group, Eli Lilly, HLS Therapeutics, Humber River Health, Janssen, Novartis, Novo Nordisk, Pfizer, PhaseBio, S & L Solutions Event Management Inc: Speakers Bureau; Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Eli Lilly, HLS Therapeutics, Janssen, Novartis, Novo Nordisk, Sanofi: Consultant/Advisory Board; Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Eli Lilly, HLS Therapeutics, Merck, Novartis, Novo Nordisk, Pfizer, PhaseBio, Sanofi: Other Research Support